. Overall, RNA or DNA-based models combining immune and tumor measures improve predictions of melanoma CPB outcomes.
No takes yet. Share an insight, caveat, or question.
Freeman et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: